These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 14733419

  • 1. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C, Martino R, Selvaggiolo M, Bona RM, Cazzato F, Milano R, Chiarulli G, Basile C.
    J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
    [Abstract] [Full Text] [Related]

  • 2. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands.
    Lomonte C, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C.
    J Nephrol; 2005; 18(1):92-5. PubMed ID: 15772929
    [Abstract] [Full Text] [Related]

  • 3. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia.
    Basile C, Lomonte C, Vernaglione L, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Cazzato F.
    Nephrol Dial Transplant; 2006 Apr; 21(4):968-74. PubMed ID: 16326747
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index.
    Lomonte C, Vernaglione L, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Basile C.
    J Nephrol; 2006 Nov; 19(1):70-6. PubMed ID: 16523429
    [Abstract] [Full Text] [Related]

  • 6. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
    Malberti F, Corradi B, Cosci P, Colecchia M, Leopardi O, Grossi L, Oldini C, Imbasciati E.
    Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
    [Abstract] [Full Text] [Related]

  • 7. Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism.
    Yamada S, Taniguchi M, Tokumoto M, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2010 Aug 01; 14(4):424-31. PubMed ID: 20649764
    [Abstract] [Full Text] [Related]

  • 8. Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?
    Lomonte C, Vernaglione L, Chimienti D, Bruno A, Cocola S, Teutonico A, Cazzato F, Basile C.
    Clin J Am Soc Nephrol; 2008 May 01; 3(3):794-9. PubMed ID: 18322048
    [Abstract] [Full Text] [Related]

  • 9. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage.
    Grekas D, Balaskas E, Kampouris H, Benos A, Konstantinou A, Sioullis A, Tourkantonis A.
    Clin Nephrol; 1999 Sep 01; 52(3):167-71. PubMed ID: 10499312
    [Abstract] [Full Text] [Related]

  • 10. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
    Romanini D, Gazo A, Bellazzi R, de Vincenzi A, Nai M, Santagostino M.
    Adv Perit Dial; 1994 Sep 01; 10():267-9. PubMed ID: 7999842
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.
    Rashed A, Fahmi M, ElSayed M, Aboud O, Asim M.
    Transplant Proc; 2004 Sep 01; 36(6):1815-7. PubMed ID: 15350484
    [Abstract] [Full Text] [Related]

  • 12. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
    Delmez JA, Kelber J, Norwood KY, Giles KS, Slatopolsky E.
    Clin Nephrol; 2000 Oct 01; 54(4):301-8. PubMed ID: 11076106
    [Abstract] [Full Text] [Related]

  • 13. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
    Fujimori A, Sakai M, Yoshiya K, Shin J, Kim JI, Inaba Y, Miyamoto T, Inoue S, Fukagawa M.
    Ther Apher Dial; 2004 Dec 01; 8(6):474-9. PubMed ID: 15663547
    [Abstract] [Full Text] [Related]

  • 14. Cases with fewer than four parathyroid glands in patients with renal hyperparathyroidism at initial parathyroidectomy.
    Hibi Y, Tominaga Y, Uchida K, Takagi H, Imai T, Funahashi H, Nakao A.
    World J Surg; 2002 Mar 01; 26(3):314-7. PubMed ID: 11865367
    [Abstract] [Full Text] [Related]

  • 15. Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy.
    Lomonte C, Antonelli M, Losurdo N, Marchio G, Giammaria B, Basile C.
    Nephrol Dial Transplant; 2007 Jul 01; 22(7):2056-62. PubMed ID: 17449495
    [Abstract] [Full Text] [Related]

  • 16. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
    Tominaga Y, Matsuoka S, Sato T, Uno N, Goto N, Katayama A, Haba T, Kazuharu Uchida (Yagoto PTx Forum).
    Ther Apher Dial; 2007 Aug 01; 11(4):266-73. PubMed ID: 17661832
    [Abstract] [Full Text] [Related]

  • 17. [Pulsed doses of calcitriol in the treatment of secondary hyperparathyroidism in patients on hemodialysis].
    Sotorník I, Petrásek R, Schück O, Adamec M, Smrcková I, Tocík J.
    Vnitr Lek; 1997 Sep 01; 43(9):584-91. PubMed ID: 9750467
    [Abstract] [Full Text] [Related]

  • 18. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H, Koiwa F, Shishido K, Takahashi K, Ito H, Kinugasa E, Taguchi S.
    Ther Apher Dial; 2007 Jun 01; 11(3):202-9. PubMed ID: 17498002
    [Abstract] [Full Text] [Related]

  • 19. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
    Am J Nephrol; 2008 Jun 01; 28(1):97-106. PubMed ID: 17914251
    [Abstract] [Full Text] [Related]

  • 20. BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients.
    Borràs M, Torregrossa V, Oliveras A, Almirall J, Ma Paz M, Betriu A, Martin M, Muray S, Fibla J, Fernández E.
    J Nephrol; 2003 Jun 01; 16(1):116-20. PubMed ID: 12649542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.